Bionano Genomics Mon, September 21, 2020, 2:00 PM GMT+2 SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Erik Holmlin, Ph.D., CEO of Bionano, will present a company overview and be available for virtual one-on-one meetings with investors at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit taking place virtually on September 21-23, 2020. |